Tocqueville Asset Management’s Lifecore Biomedical LFCR Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.23M | Hold |
151,700
| – | – | 0.02% | 336 |
|
2025
Q1 | $1.07M | Hold |
151,700
| – | – | 0.02% | 335 |
|
2024
Q4 | $1.13M | Hold |
151,700
| – | – | 0.02% | 347 |
|
2024
Q3 | $748K | Hold |
151,700
| – | – | 0.01% | 371 |
|
2024
Q2 | $778K | Sell |
151,700
-200,000
| -57% | -$1.03M | 0.01% | 359 |
|
2024
Q1 | $1.87M | Sell |
351,700
-50,000
| -12% | -$266K | 0.03% | 278 |
|
2023
Q4 | $2.49M | Hold |
401,700
| – | – | 0.05% | 237 |
|
2023
Q3 | $3.03M | Sell |
401,700
-50,000
| -11% | -$377K | 0.06% | 222 |
|
2023
Q2 | $4.37M | Sell |
451,700
-93,500
| -17% | -$904K | 0.08% | 192 |
|
2023
Q1 | $2.06M | Sell |
545,200
-13,300
| -2% | -$50.2K | 0.04% | 263 |
|
2022
Q4 | $3.62M | Sell |
558,500
-44,400
| -7% | -$288K | 0.07% | 219 |
|
2022
Q3 | $5.36M | Sell |
602,900
-5,550
| -0.9% | -$49.3K | 0.11% | 173 |
|
2022
Q2 | $6.07M | Buy |
608,450
+115,000
| +23% | +$1.15M | 0.11% | 180 |
|
2022
Q1 | $5.71M | Buy |
493,450
+71,500
| +17% | +$828K | 0.09% | 217 |
|
2021
Q4 | $4.68M | Buy |
421,950
+131,850
| +45% | +$1.46M | 0.06% | 262 |
|
2021
Q3 | $2.68M | Buy |
290,100
+40,000
| +16% | +$369K | 0.04% | 327 |
|
2021
Q2 | $2.81M | Buy |
250,100
+94,300
| +61% | +$1.06M | 0.04% | 334 |
|
2021
Q1 | $1.65M | Buy |
155,800
+32,900
| +27% | +$349K | 0.03% | 389 |
|
2020
Q4 | $1.33M | Hold |
122,900
| – | – | 0.02% | 399 |
|
2020
Q3 | $1.2M | Buy |
122,900
+1,300
| +1% | +$12.6K | 0.02% | 377 |
|
2020
Q2 | $968K | Buy |
121,600
+2,800
| +2% | +$22.3K | 0.02% | 394 |
|
2020
Q1 | $1.03M | Buy |
118,800
+5,350
| +5% | +$46.5K | 0.03% | 351 |
|
2019
Q4 | $1.28M | Hold |
113,450
| – | – | 0.02% | 415 |
|
2019
Q3 | $1.23M | Hold |
113,450
| – | – | 0.02% | 435 |
|
2019
Q2 | $1.06M | Buy |
+113,450
| New | +$1.06M | 0.01% | 474 |
|
2013
Q3 | – | Sell |
-18,474
| Closed | -$244K | – | 936 |
|
2013
Q2 | $244K | Buy |
+18,474
| New | +$244K | ﹤0.01% | 834 |
|